Thyrocare Technologies Limited Financial Ratios
THYROCARE · Healthcare · Current price ₹485.5
P/E ratio
47.3x
P/B ratio
17.3x
ROE
27.8%
ROCE
33.9%
Debt / Equity
0.09
Dividend yield
2.5%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 47.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 17.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 27.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 33.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.09 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Thyrocare Technologies Limited's latest numbers.
Thyrocare Technologies Limited profitability
Thyrocare Technologies Limited generates a return on equity of 27.8% and a return on capital employed of 33.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.09 and a P/E of 47.3x, Thyrocare Technologies Limited is conservatively financed. Our overall business-quality score for the company is 6.8 / 10.
Understand the ratios
More on Thyrocare Technologies Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.